07:00 , Jul 11, 2016 |  BC Week In Review  |  Financial News

AntriaBio completes private placement of units

AntriaBio Inc. (OTCQB:ANTB), Menlo Park, Calif.   Business: Endocrine/Metabolic   Date completed: 2016-06-28   Type: Private placement of units   Raised: $1.9 million   Units: 1.7 million   Price: $1.10 (unit)   Shares after offering:...
08:00 , Dec 14, 2015 |  BC Week In Review  |  Financial News

AntriaBio completes private placement of convertible preferred stock

AntriaBio Inc. (OTCQB:ANTB), Menlo Park, Calif.   Business: Endocrine/Metabolic   Date completed: 2015-12-10   Type: Private placement of convertible preferred stock   Raised: $2 million   Shares: 1 million   Price: $1.95   Shares outstanding...
07:00 , Jul 13, 2015 |  BC Week In Review  |  Clinical News

AntriaBio preclinical data

AntriaBio said a single subcutaneous dose of 37.5 mg/kg AB101 in rats and a single subcutaneous dose of 10 or 37.5 mg/kg AB101 in dogs led to a maximum insulin concentration (Cmax) of >30 ng/mL...
08:00 , Jan 12, 2015 |  BC Week In Review  |  Financial News

AntriaBio completes private placement of units

AntriaBio Inc. (OTCQB:ANTB), Menlo Park, Calif.   Business: Endocrine/Metabolic   Date completed: 2015-01-05   Type: Private placement of units   Raised: $3.6 million   Units: 2 million   Price: $1.85 (unit)   Shares after offering:...
07:00 , May 5, 2014 |  BC Week In Review  |  Financial News

AntriaBio financial update

AntriaBio implemented a 1-for-6 reverse stock split and began trading under the ticker "ANTBD." Following the split, AntriaBio has about 17.1 million shares outstanding. AntriaBio Inc. (OTCQB:ANTBD), Menlo Park, Calif.   Business: Endocrine/Metabolic   Date...
07:00 , Apr 7, 2014 |  BC Week In Review  |  Financial News

AntriaBio completes private placement of units

AntriaBio Inc. (OTCQB:ANTB), Menlo Park, Calif.   Business: Endocrine/Metabolic   Date completed: 4/1/14   Type: Private placement of units   Raised: $7.3 million   Units: 28.1 million   Price: $0.26 (unit)   Shares after offering:...
08:00 , Jan 20, 2014 |  BC Week In Review  |  Financial News

AntriaBio completes private placement of convertible notes and warrants

AntriaBio Inc. (OTCQB:ANTB), Menlo Park, Calif.   Business: Endocrine/Metabolic   Date completed: 1/16/14   Type: Private placement of convertible notes and warrants   Raised: $2.7 million   Placement agent: Paulson Investment   Shares outstanding prior:...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Company News

AntriaBio board of directors update

AntriaBio Inc. (OTCQB:ANTB), Menlo Park, Calif.   Business: Endocrine/Metabolic   Appointed: CEO Nevan Elam as chairman; he replaces Steve Howe, who resigned as chairman while remaining a director  ...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Financial News

AntriaBio withdraws private placement of units

AntriaBio Inc. (OTCQB:ANTB), Menlo Park, Calif.   Business: Endocrine/Metabolic   Date announced: 12/18/13   Type: Private placement of units   Placement agent: Ladenburg Thalmann   Note: AntriaBio withdrew the offering after terminating its agreement with...
07:00 , Oct 7, 2013 |  BC Week In Review  |  Financial News

AntriaBio proposes private placement of units

AntriaBio Inc. (OTCQB:ANTB), Menlo Park, Calif.   Business: Endocrine/Metabolic   Date announced: 9/30/13   Type: Private placement of units   To be raised: Up to $12 million   Units: TBD   Price prior: $0.60  ...